Experimental IgE-mediated food allergy depends on intestinal anaphylaxis driven by interleukin-9 (IL-9). However, the primary cellular source of IL-9 and the mechanisms underlying the susceptibility to food-induced intestinal anaphylaxis remain unclear. Herein, we have reported the identification of multifunctional IL-9-producing mucosal mast cells (MMC9s) that can secrete prodigious amounts of IL-9 and IL-13 in response to IL-33, and mast cell protease-1 (MCPt-1) in response to antigen and IgE complex crosslinking, respectively. Repeated intragastric antigen challenge induced MMC9 development that required T cells, IL-4, and STAT6 transcription factor, but not IL-9 signals. Mice ablated of MMC9 induction failed to develop intestinal mastocytosis, which resulted in decreased food allergy symptoms that could be restored by adoptively transferred MMC9s. Finally, atopic patients that developed food allergy displayed increased intestinal expression of Il9-and MC-specific transcripts. Thus, the induction of MMC9s is a pivotal step to acquire the susceptibility to IgE-mediated food allergy.
In Brief
Current knowledge cannot explain why only some patients and murine strains that acquire high amounts of dietary allergen-specific IgE develop lifethreatening anaphylaxis. Wang and colleagues identify and characterize the IL-9-producing mucosal mast cells that amplify anaphylactic response to dietary proteins by producing large amounts of IL-9 and mast cell mediators.
INTRODUCTION
IgE-mediated food allergy is an immediate hypersensitivity reaction that can affect multiple organ systems. Clinical symptoms of food allergy patients range from a mild skin reaction to lethal shock (Boyce et al., 2010; Sicherer and Sampson, 2010) . The anaphylactic response to ingested food antigens usually results from the activation of intestinal mast cells (MCs) through food-specific IgE antibodies (Finkelman, 2007; Galli and Tsai, 2012) . However, it is perplexing as to why only some patients and murine strains that acquire high amounts of dietary allergen-specific IgE develop a severe immediate intestinal hypersensitivity response that can result in life-threatening anaphylaxis.
The T helper 2 (Th2) cell cytokine interleukin (IL)-4 plays key roles in promoting IgE antibody production and intestinal allergic inflammation that are required for IgE-mediated food allergy (Berin and Mayer, 2009; Brandt et al., 2009; Forbes et al., 2008; Strait et al., 2011; Vickery et al., 2011) . Mice deficient in Il4 produce little IgE antibody and are resistant to developing experimental food allergy (Brandt et al., 2009; Kweon et al., 2000) . In contrast, mice harboring an activating mutation of the IL-4 receptor a chain (Il4raF709) produce elevated antigenspecific IgE antibodies and are more susceptible to this disorder (Mathias et al., 2011) . In addition to IL-4, recent studies point to a pivotal role for IL-9 in promoting intestinal mastocytosis and driving experimental food allergy (Forbes et al., 2008; Osterfeld et al., 2010) . Repeated intragastric ovalbumin (OVA) challenge fails to increase intestinal mastocytosis, serum mast cell protease-1 (MCPt-1), the incidence of allergic diarrhea, or hypothermia in sensitized IL-9-or IL-9R-deficient mice, even though they produced OVA-specific IgE and IgG normally (Osterfeld et al., 2010) . In contrast, transgenic mice that constitutively overexpress intestinal-specific IL-9 are more prone to develop experimental food allergy (Ahrens et al., 2012; Forbes et al., 2008; Osterfeld et al., 2010) . Although these studies demonstrate a distinctive role for IL-9 in promoting experimental food allergy, the primary cellular source of IL-9 and the mechanisms that underlie the susceptibility to intestinal anaphylaxis have not been established. Herein, we report the identification of IL-9-producing mucosal mast cells (MMC9s) and show that the acquisition of MMC9s increases the susceptibility to IgEmediated experimental food allergy.
RESULTS

Mice Susceptible to Food Allergy Have Increased Lineage
-IL-9-Producing Cells Just as allergen-sensitized patients have varying degrees of susceptibility to food allergens, OVA-sensitized murine strains differ in their susceptibility to anaphylactic responses to ingested OVA (Helm and Burks, 2002) . Intestinal IL-9 production is important for the development of experimental food allergy (Forbes et al., 2008; Osterfeld et al., 2010) , so we first examined and compared the frequency of IL-9-producing cells among lamina propria (LP) mononuclear cells in the small intestine of different immunized murine strains. Although some CD3 + CD4 + T cells produced IL-9, most of the IL-9-producing LP cells in BALB/c, A/J, and C3H/HeJ mice did not express cell lineage markers (Lin À ) ( Figure 1A ). Among the examined murine strains, sensitized BALB/c mice were the most likely to develop experimental Fraction indicates incidences of allergic diarrhea (B) and hypothermia (C). Error bars denote mean ± SEM. *p % 0.05; **p % 0.01; ***p % 0.001. NS, not significant. See also Figure S1 .
food allergy after six intragastric OVA challenges, with BALB/c mice exhibiting higher incidences of allergic diarrhea and hypothermia (91.7%, 50.0%) as compared to A/J (50.0%, 8.3%), C3H/ HeJ (12.5%, 0.0%), and C57BL/6 (0.0%, 0.0%) mice ( Figures 1B and 1C) . Notably, murine strains that were more susceptible to experimental food allergy, as manifested by allergic diarrhea and hypothermia, also exhibited higher amounts of intestinal mastocytosis ( Figure 1D ) and serum MCPt-1 (which reflects mast cell degranulation) ( Figure 1E ), whereas all murine strains were capable of producing considerable amounts of serum OVAspecific IgE or IgG ( Figures 1F and 1G ). BALB/c mice had the highest frequency of intestinal Lin À IL-9-producing LP cells (16.7% ± 2.0%, mean ± SEM) and were also the most susceptible strain to experimental food allergy, whereas C57BL/6 mice lacked the Lin À IL-9-producing cell population and failed to develop experimental food allergy . Immunized A/J and C3H/ HeJ strains had 6.0% ± 1.1% and 1.0% ± 0.3%, Lin À IL-9-producing LP cells, respectively, and were less susceptible to developing experimental food allergy ( Figures 1A and 1B-1H ).
Similarly, a higher frequency of LinˉIL-9-producing LP cells (4.5%) was induced in sensitized CBA mice than those in DBA2 (1.8%) and 129 (2.0%) mice after repeated challenges ( Figure S1A ). Immunized CBA mice also displayed more pronounced intestinal mastocytosis, produced more MCPt-1, and were more susceptible to experimental food allergy, while producing comparable amounts of OVA-specific IgE among these murine strains ( Figures S1B-1E ). Anatomically, these Lin À IL-9-producing cells resided primarily within the LP, not the intraepithelium of the small intestine, and very few of these cells resided in the Peyer's patch (PP), mesenteric lymph nodes (MLNs), spleen, lung, or liver ( Figure 1I ). Together, these results suggest an association of Lin À IL-9-producing LP cells with the susceptibility to experimental food allergy.
Innate MMC9s Are the Principal IL-9 Producers of Mast Cell Lineage A previous report demonstrated that type 2 innate lymphoid cells (ILC2s) lack cell lineage markers and have the potential to produce IL-9 (Wilhelm et al., 2011) . To determine whether these intestinal Lin À IL-9-producing cells were ILC2s, we generated a monoclonal antibody against an IL-25 receptor component, IL-17RB, the characteristic marker for ILC2s (Neill et al., 2010) and employed BALB/c IL-4-eGFP (4GET) mice that can be used to track ILC2s by their GFP expression in our murine model of food allergy. adhesion molecule that characterizes previously described intestinal mast cell progenitors (MCPs) ( Figure 2C ; Chen et al., 2005; Gurish et al., 2001) . Intracellular cytokine analysis demonstrated that the principle IL-9 producers were the b7integrin 
IL-17RB
+ cells underwent an expansion and produced large amounts of IL-5 and IL-13, along with a small amount of IL-9 after culture with IL-25 and/or IL-33 in the presence of IL-7; in contrast, MMC9s, which lacked IL-17RB, did not respond to these stimuli and perished ( Figure S3B and data not shown; Wilhelm et al., 2011 transcripts ( Figure 2E and data not shown). In this regard, the Lin À GFP hi IL-17RB + c-Kitˉcells detected in our murine model of food allergy appeared identical to the intestinal IL-25-responding ILC2s that have previously been shown to elicit protective immunity against intestinal worm infection (Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Saenz et al., 2010) . In contrast, MMC9s did not respond to IL-25 stimulation in vitro and in vivo and are distinct from both ILC2s and the previously reported IL-25-elicited c-Kit int -GFP + multipotent progenitor (MPP type2 ) (Saenz et al., 2010 
Bone Marrow MCPs Give Rise to Intestinal MMC9s
To examine the MC lineage origin of intestinal MMC9s in vivo, we first established a reconstitution model of experimental food allergy by adoptively transferring bone marrow (BM) cells from 4GET mice into OVA-sensitized BALB/c mice 1 day after sublethal irradiation (protocol diagramed in Figure S4A ). After the second sensitization and repeated intragastric OVA challenge, transferred BM cells replenished the majority of MCPs and MMC9s, which were marked with GFP, in the irradiated recipients ( Figure S4B ). In contrast, most CD4 + IL-17RB + ST2 + Th2 cells were derived from the sensitized recipients as shown by their lack of GFP expression ( Figure S4C ). Compared to reconstituted mice that were challenged with saline only, repeated intragastric OVA challenge triggered a substantial increase in donor-derived (>95% GFP hi ) MMC9s and recipient-derived (>98% GFP
+ Th2 cells (Figures S4B and S4C) . This is probably because donor-derived hematopoietic progenitors will reconstitute innate MC lineage within 2 weeks, whereas de novo T cell generation after thymus engraftment requires >2 months (Spangrude and Scollay, 1990 after repeated intragastric OVA challenge ( Figure S4D ). Next, we showed that purified BM MCPs (defined as Lin (Franco et al., 2010 ) from 4GET mice gave rise to intestinal GFP-expressing MCPs and MMC9s, and repeated intragastric OVA challenge triggered a significant increase of both MMC9s and MCs in the sensitized recipients, which eventually developed symptoms of experimental food allergy ( Figures 3A-3C Figures 4A-4F , and data not shown). Furthermore, analysis of seven murine strains showed that the concomitant increase of MMC9 and CD4 + IL-17RB + Th2 cells was much greater in murine strains that were prone to develop experimental food allergy (i.e., BALB/c, A/J, and CBA) than in those that were resistant to developing experimental food allergy (i.e., C3H/HeJ, DBA2, 129, and C57BL/6) ( Figures 1A-1H , 4G, and S1). In contrast, the frequencies of ILC2s ($2.0%) and basophils (<0.1%) remained constant even after the examined murine strains were subjected to stimuli that induce intestinal anaphylaxis (data not shown). Similarly, skin-sensitized mice by vitamin D3 analog (Calcipotriol) also developed strong MMC9 (>3.5%) and CD4 + Th2 (>2%) immune response, resulting in pronounced intestinal mastocytosis and increased MCPt-1 production after repeated intragastric OVA challenge ( Figures S5A-S5D) . However, we failed to detect significant induction of MMC9s (<1%) and CD4 + Th2 cells (<1%) in cholera toxin (CT)-sensitized C3H/HeJ or BALB/c mice that displayed few intestinal MC numbers and produced low MCPt-1 titer after repeated intragastric OVA challenge ( Figures S5E-S5G ). These results demonstrate that repeated oral antigen challenge triggers substantial accumulations of MMC9s and CD4 + Th2 cells, but not MCPs, MMC9 Induction Requires CD4 + Th2 Cells To understand the requirements for MMC9 induction, we first analyzed genetically modified mice that were resistant to developing experimental food allergy. Compared to WT mice, sensitized BALB/c IL-4-, IL-4Ra-, STAT6-, or Rag-2-deficient mice and T-cell-deficient nude mice were less competent to recruit MCPs, failed to develop MMC9s, and subsequently were resistant to develop features of food allergy after repeated intragastric OVA challenge ( Figures 5A-5C and data not shown). Anti-CD4 mAb ablation of T cells before challenge suppressed MMC9 induction but not MCP recruitment in sensitized mice and prevented the development of experimental food allergy ( Figures  5D-5F Figures 5G-5I) . Collectively, these results demonstrate that the induction of MMC9s requires T cells and IL-4 signals and that an intact Th2 cell microenvironment, provided by CD4 + Th2 cells, induces MMC9s that promote experimental food allergy.
IL-9 Signals Promote MMC9 Expansion and Intestinal
Mastocytosis IL-9 plays an important role in MC development and growth (Goswami and Kaplan, 2011) , so we examined the requirements of IL-9 and IL-9R in the MMC9 induction. Although the MCP and MMC9 accumulations occurred normally, many fewer sensitized IL-9-and IL-9R-deficient mice developed a diarrheal response and had significantly reduced intestinal MC number and serum MCPt-1, despite normal OVA-specific IgE titers (Figures 6A-6E ). The failure to develop experimental food allergy in Il9
and Il9r À/À mice could be restored after the reconstitution with WT BM cells ( Figures S6A-S6C ), because BM MCPs purified from 4GET mice could reconstitute GFP + MMC9s that promoted intestinal mastocytosis in Il9 À/À recipients ( Figure S6D ).
In contrast, IL-9-or IL-9R-deficient BM cells failed to restore the susceptibility to developing experimental food allergy in the irradiated 4GET recipients, despite significant generations of GFP À MMC9s deficient of IL-9 or IL-9R ( Figures 6F-6I ). Additionally, IL-9R-deficient BM cells were less efficient than WT or IL-9-deficient BM cells to reconstitute GFP À MMC9s ( Figures 6F-6I ), possibly due to alternative IL-9 sources produced by recipient's CD4 + Th2 cells and/or ILC2s that were sufficient to enhance MMC9 expansion ( Figures 6F-6H, 1A , and 2E). Finally, reconstitution with purified WT, not IL-9-deficient, MMC9s could directly promote intestinal mastocytosis and restore the propensity to develop experimental food allergy in sensitized recipients that lacked an alternative source of IL-9 ( Figure S6E ). These results suggest that IL-9 and IL-9R are dispensable for MMC9 development but are necessary for effective expansion of MMC9s that promote intestinal mastocytosis and susceptibility to experimental food allergy in an IL-9-dependent autocrine manner.
MMC9 Induction Augments Intestinal Mastocytosis that Drives Experimental Food Allergy
To directly demonstrate that MMC9 induction is a key step for the amplification of intestinal mastocytosis that promotes the development of experimental food allergy, we treated OVAsensitized BALB/c WT mice with anti-FcεRIa mAb before and during the course of repeated intragastric OVA challenge. AntiFcεRIa mAb treatment efficiently ablated MCPs and MMC9s as evidenced by a $90% decrease in Lin À IL-9-producing cells ( Figures 7A and 7B ). The loss of MCPs and MMC9s was associated with decreased MC number and goblet cell hyperplasia, and serum MCPt-1, and the failure to develop allergic diarrhea after repeated intragastric OVA challenge ( Figures 7B-7D ). Importantly, transfer of purified MMC9s to mice that had been treated with anti-FcεRIa mAb accelerated restoration of the ability to develop intestinal mastocytosis and promoted their development of allergic diarrhea after repeated intragastric OVA challenges ( Figures 7E and 7F ). Compared to WT mice, much fewer intestinal MCPs and MMC9s were induced in sensitized Fcer1a À/À mice, which consequently exhibited less intestinal mastocytosis, produced fewer MCPt-1, and failed to develop food allergy ( Figures S7A-S7C ). These results further demonstrate that MMC9s drive intestinal mastocytosis to promote the susceptibility to experimental food allergy in an FcεR-dependent manner.
Food Allergy Patients Display Increased Expression of Il9 and Mast Cell-Specific Transcripts
To evaluate a biological relevance of MMC9 induction in human food allergy, we analyzed the expression of MMC9 signature transcripts in the duodenum of patients who had defined food allergy characteristics (Table S1 ). Notably, expression of Il9 and Il13 and mast cell transcripts, such as carboxypeptidase A3 (Cpa3), tryptase, and chymase, were significantly increased in the duodenum of food allergy patients than those in control subjects ( Figure 7G ). These results suggest that increased expression of both Il9-and MC-specific transcripts in the small intestine might be associated with atopic patients that developed food allergy.
DISCUSSION
The prevalence of food-induced allergic disorders has increased substantially in industrialized countries over the past decade (Gupta et al., 2011) . Current knowledge cannot explain why only some individuals who have high titers of dietary allergen-specific serum IgE develop life-threatening intestinal anaphylaxis. In this study, we have reported the identification of IL-9-producing mucosal mast cells, MMC9s, which were preferentially induced in murine strains susceptible to food allergy. MMC9s secreted large amounts of IL-9 and IL-13 in response to IL-33, and MCPt-1 protein and histamine in response to IgE-bound FcεR complex cross-linking by antigens. Given their anatomical location, characteristics, and function, MMC9s might be a key player that amplifies intestinal allergic (Miller and Pemberton, 2002; Welle, 1997) . (2) MMC9s originate from bone marrow MCPs. (3) MMC9s exhibit a small progenitor-like morphology with few metachromatic granules in their scanty cytoplasm, the defining mucosal MC characteristics (Beaven, 2009) . (4) MMC9s mature into granular MCs, but possess very poor proliferative capacity. (5) MMC9s produce prodigious amounts of IL-9, the key cytokine for the proliferation, maturation, and activation of MCs (Goswami and Kaplan, 2011; Renauld et al., 1995) . (6) MMC9s are distinct from other IL-4-and IL-13-producing non-lymphoid cells (MCs, basophils, and eosinophils), which develop normally in STAT6-or IL-4Ra-deficient mice (Gessner et al., 2005) , inasmuch as MMC9 development requires the IL-4 and STAT6 signals. (7) IL-9 and IL-9R signals are important to establish pulmonary and intestinal mastocytosis (Osterfeld et al., 2010; Townsend et al., 2000) but are dispensable for MMC9 induction. Thus, MMC9s might represent Th2 cytokine-producing innate cells that follow the common myeloid progenitor (CMP) and granulocyte-macrophage progenitor (GMP) developmental pathway, paralleling ILC2s, a member of ILC family that develops through the common lymphoid (CLP) pathway (Arinobu et al., 2005) .
The interplay between MMC9s and CD4 + Th2 cells appears to be a key mechanism that governs the susceptibility to and severity of experimental food allergy. Among seven examined murine strains, the frequencies of intestinal b7 hi MCPs ($0.2%) and b7 lo MMC9s ($0.1%) were initially comparable before sensitization, except C57BL/6 mice that fail to develop MMC9s. After repeated challenge, MMC9 and CD4 + Th2 cell frequencies were concomitantly higher in sensitized BALB/c, A/J, and CBA mice than those in DBA2, 129, and C3H/HeJ mice. Consequently, BALB/c, A/J, and CBA mice exhibited increased intestinal MC numbers, serum MCPt-1 titers, and the propensity to develop experimental food allergy, despite the fact that murine strains DBA2, 129, and CBA share the same MHC H2 haplotype with BALB/c (H2
and C3H/HeJ (H2 k ), respectively. Finally, mice ablated of or deficient in T cells or IL-4 signaling had reduced capacity to accumulate intestinal MCPs and failed to develop MMC9s. Thus, the ability of murine strains to mount the intestinal CD4 + Th2-cell-mediated immune response to ingested dietary antigens, not their MHC H2 haplotype, correlated positively with MMC9 frequency, and consequently, susceptibility to food allergy. Whether our findings of MMC9s and its dependence on CD4 + Th2 cells pertain to helminth-induced T-cell-dependent mucosal MCs and IL-9 dependence of the protective response to Trichinella spiralis infection remains to be investigated (Angkasekwinai et al., 2013; Dillon and MacDonald, 1986; Liu et al., 2013; Ruitenberg and Elgersma, 1976; Urban et al., 2000) . Several murine models have been developed in an attempt to understand the immunological mechanisms underlying the susceptibility of food allergy. In addition to adjuvant alum that induces a strong allergic sensitization, administration of CT intragastrically could also break oral tolerance and induce elevated histamine, IgE, and IgG1 titers, resulting in systemic anaphylactic responses to ingested allergen, which occurred selectively in C3H/HeJ strain (Li et al., 1999; Morafo et al., 2003) . In contrast to sensitization via alum adjuvant, repeated intragastric OVA challenge failed to induce strong MMC9 (<1%) and CD4 + Th2 (<1%) immune responses in CT-sensitized C3H/HeJ or BALB/c mice, despite inducing a strong humoral immune response. Consequently, much fewer intestinal MC numbers and serum MCPt-1 titers ($15 cells/mm 2 and $2 mg/ml) were induced in CT-sensitized C3H/HeJ or BALB/c mice than those ($400 cells/mm 2 and $20 mg/ml) detected in alum-sensitized BALB/c mice (Li et al., 1999; Morafo et al., 2003) . Additionally, a significant increase of intestinal MMC9 frequency, mucosal MC number, and serum MCPt-1 titer could be observed in the vitamin D3 analog (Calcipotriol)-, not vehicle-, sensitized mice after repeated intragastric OVA antigen challenge. These findings suggest that MMC9 induction can occur in mice sensitized with ''atopic-promoting'' adjuvants, such as alum and vitamin D3 analog, which preferentially prime Th2 cell immune response. Importantly, the finding that Fcer1a À/À mice exhibited reduced intestinal MCP recruitment, MMC9 induction, and MC number and failed to develop food allergy further underscores that the alum-sensitized model of food allergy is dependent on the classical IgE-mediated MC and FcεR pathway (Ahrens et al., 2012; Osterfeld et al., 2010) . In contrast, the genetic susceptibility (Morafo et al., 2003) , Tlr4 mutation (Bashir et al., 2004) , and/or the alternative pathway mediated by IgG and FcgR complex (Smit et al., 2011) have been implicated in contributing to the susceptibility of C3H/HeJ strain to systemic anaphylaxis after CT sensitization. Because MMC9s have limited proliferative potential, it is plausible to propose that crosslinking of IgE-bound FcεR complexes by dietary antigens results in a strong proliferation of BM-derived MCPs, which then develop into MMC9s in the presence of intestinal CD4 + Th2 cells induced by ingested food allergens. These induced MMC9s might later mature into granular MCs or alternatively promote MCP maturation directly, in an IL-9-dependent manner. Additionally, our findings also suggest that MMC9s amplify intestinal mastocytosis by producing IL-9 in response to alarmin IL-33 and by releasing proteases in response to dietary antigen crosslinking of IgE-bound FcεR complexes; consequently, they serve as innate myeloid helper cells to promote the development of IgE-mediated food allergy. Indeed, the association between increased numbers of duodenal IgE-positive MCs and food allergy has been observed in clinical studies (Bengtsson et al., 1991; Caffarelli et al., 1998) . Furthermore, the expression of both Th2 cytokine Il9 and Il13 and mast-cell-specific Cpa3, tryptase, and chymase transcripts were significantly increased in the duodenum of atopic patients that developed food allergy. After re-stimulation with PMA and ionomycin and treatment with Golgi blocker, enriched Lin À LP cells were stained with PE-anti-b7integrin, APC-Cy7-conjugated anti-c-Kit, and biotinylated anti-T1/ST2 antibodies. Subsequently, cells were counterstained with PerCP-Cy5.5-conjugated monoclonal antibodies against Lin markers (including CD3 and CD4) and with Brilliant Violet 421-labeled streptavidin. Stained cells were fixed and permeabilized for intracellular cytokine staining using FITC-anti-IFN-g (XMG 1.2) and APC-anti-IL-9 (RM9A4) or APC-anti-IL-13 (eBio13A).
IgE-Mediated Experimental Food Allergy
Mice were sensitized twice within a 2-week interval by intraperitoneal (i.p.) injection with 100 mg OVA and 1 mg alum and then orally gavaged with OVA (50 mg in 250 ml saline) six times within 2 weeks. In prophylactic experiments, sensitized BALB/c mice were injected intraperitoneally with 500 mg anti-FcεRIa (MAR-1) antibody (Biolegend) or hamster isotype control antibody (Bio X Cell) or with 500 mg of anti-CD4 (GK1.5) antibody (Bio X Cell) or rat isotype control antibody (Bio X Cell) twice 1 day before the first and fourth intragastric OVA challenges. Some antibody-treated mice were rested for 2 weeks after the sixth OVA challenge before reconstitution with 1 3 10 6 purified MMC9s by retro-orbital injection. At 1 day after adoptive transfer, mice were re-challenged with OVA intragastrically, then re-challenged every other day until they developed allergic diarrhea.
Measurement of Parameters of Food Allergy
Serum samples were analyzed with ELISA kits for OVA-specific IgE (MD Bioproducts), MCPt-1 (eBioscience), and OVA-specific IgG1 (alpha diagnostic international). For intestinal histological analyses, duodenal tissue was fixed in 10% formalin and processed by standard histological techniques. 5-mm tissue sections were stained with Leder stain for chloroacetate esterase (CAE) activity in intestinal mast cells or periodic acid-Schiff (PAS) for mucins in goblet cells. Stained cells were quantified as previously described (Brandt et al., 2003) . Assessment of diarrhea and measurement of hyperthermia (rectal temperature drop > 2 C) were performed as previously described (Osterfeld et al., 2010) .
Measurement of Cytokines and Mediators
Purified MCPs, MMC9s, and ILC2s (5 3 10 4 ) from mice with active allergic diarrhea were stimulated with PMA (0.1 mg/ml) and ionomycin (1 mg/ml) for 1 day or with the indicated cytokines for 3 days before the collection of supernatants. CD4 + GFP hi Th2 cells (5 3 10 4 ) were stimulated with plate-bound anti-CD3
(5 mg/ml) and soluble anti-CD28 (1 mg/ml) for 24 hr. Secreted cytokines in supernatants were assessed by ELISA kits for IL-5 (R&D), IL-9 (Biolegend), IL-4, IFN-g, IL-17A (BD Bioscience), and IL-13 (Antigenic American). Secreted MCPt-1 was measured by ELISA (eBioscience). BMMCs were derived and degranulation assays were performed as previously described (Arumugam et al., 2011) . Secreted b-hexoaminidase activity was measured by colorimetric determination with 4-nitrophenyl-N-acetyl-b-D-glucosaminide as described previously (Arumugam et al., 2011) . Histamine content was determined by ELISA (Beckman Coulter).
Statistical Analysis
Data are presented as the mean ± SEM. Power analysis was performed based on preliminary datasets to determine the sample sizes, which are large enough to obtain adequate statistical significance. The inclusion and exclusion criteria for murine studies were pre-established. For all murine studies, mice were assigned at random in groups. For the measurement of parameters of food allergy, studies were performed in a blinded fashion. For comparisons between groups, statistical significance was determined with a nonparametric, two-tailed Mann-Whitney t test or unpaired Student's t test. Correlation analysis was performed with a nonparametric Spearman correlation (sensitivity analyses was performed), and a linear regression of the data is displayed. Statistical tests used for all data are justified as deemed appropriate. Results are considered significant at p % 0.05. F test was used to compare variances within each group of data, and Welch's correction was used, if the variances were significantly different between groups. All data were analyzed with Prism (Graphpad Software).
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